|
As reported, prior to use for an unknown procedure, a few millimeters of a cxi support catheter's tip separated during preparation of the device.Another cxi catheter was used to successfully complete the procedure.The patient did not experience any adverse effects or require any additional procedures due to this occurrence.
|
|
Corrected information: h6 (annex a) summary of event: as reported, prior to use for an unknown procedure, a few millimeters of a cxi support catheter's tip separated during preparation of the device.Another cxi catheter was used to successfully complete the procedure.The patient did not experience any adverse effects or require any additional procedures due to this occurrence.Investigation evaluation: reviews of the complaint history, device history record (dhr), instructions for use (ifu), manufacturing instructions, and quality control procedures were conducted during the investigation.A visual inspection and dimensional verification of the complaint device was also conducted.The complaint device was returned to cook for investigation.The tip was separated.The separated tip measured 4-millimeters and the remaining tip, still attached to the catheter, also measured 4-millimeters.Two kinks were also noted on the catheter.A document-based investigation evaluation was performed.A review of the device history record found no relevant non-conformances on the final lot.Four relevant non-conformances were noted on sub-assembly lots, on four devices; however, all affected product was scrapped.A review of complaint history found no additional relevant complaints for this lot number.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.The information provided upon review of the dmr, dhr, ifu, and investigation of the returned device suggests that there is evidence the device was manufactured out of specification; however, there is no evidence of additional non-conforming devices in-house or in the field.Although four relevant non-conformances were noted on sub-assembly lots, all non-conforming product was scrapped, there are 100% inspections in place to capture this non-conformance, adequate inspection activities have been established, there is objective evidence that the dhr was fully executed, and no other lot-related complaints have been received from the field.Therefore, it was concluded that there is no evidence that additional non-conforming product exists in-house or in the field.Based on the information provided and the results of the investigation, cook has concluded that a manufacturing deficiency contributed to this event.Responsible personnel were notified.The risk analysis for this failure mode was reviewed and no additional escalation was required.The appropriate personnel have been notified and cook will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|